Abstract: The present disclosure relates to a pharmaceutical composition comprising: (a) ?-lactam antibiotics and (b) a metallo-?-lactamases (MBLs) inhibitor. The inhibitor relates to Bi(III) compounds or the pharmaceutically acceptable salts thereof. The present patent also provides methods of making Bi(III) compounds or the pharmaceutically acceptable salts thereof. Also provided is a method for treating MBLs-producing bacterial infection using a metal replacement mechanism.

Abstract: An embodiment of the present invention provides an uplink access method based on an orthogonal frequency-division multiple access mechanism, comprising: determining the number of subchannels available for a current transmission and the number of time slot blocks required for the current access; transmitting uplink access trigger frames on the available subchannels; randomly selecting among the available subchannels and the time slot blocks; and transmitting an uplink access response frame to an access point by the randomly selected available subchannel and time slot block, to perform random access. The embodiment of the present invention can reduce an average time taken by users to access channels, thereby reducing transmission delay of data packet, reducing waste of time and subchannel resources, and improving the throughput of the entire network.

Abstract: The present disclosure relates to a pharmaceutical composition comprising: (a) ?-lactam antibiotics and (b) a metallo-?-lactamases (MBLs) inhibitor. The inhibitor relates to Bi(III) compounds or the pharmaceutically acceptable salts thereof. The present patent also provides methods of making Bi(III) compounds or the pharmaceutically acceptable salts thereof. Also provided is a method for treating MBLs-producing bacterial infection using a metal replacement mechanism.

Abstract: Disclosed are a curable resin, a spacer composition, a filter, methods of preparing the same, a filter and a method of preparing the same, and a display device. The curable resin includes 1 part by weight of dianhydride, 0.6 to 2 parts by weight of diamine, and 0.8 to 3 parts by weight of vinyl monomer.

Abstract: The present disclosure relates to a pharmaceutical composition comprising: (a) ?-lactam antibiotics and (b) a metallo-?-lactamases (MBLs) inhibitor. The inhibitor relates to Bi(III) compounds or the pharmaceutically acceptable salts thereof. The present patent also provides methods of making Bi(III) compounds or the pharmaceutically acceptable salts thereof. Also provided is a method for treating MBLs-producing bacterial infection using a metal replacement mechanism.

Abstract: A speech recognition method comprises: generating, based on a preset speech knowledge source, a search space comprising preset client information and for decoding a speech signal; extracting a characteristic vector sequence of a to-be-recognized speech signal; calculating a probability at which the characteristic vector corresponds to each basic unit of the search space; and executing a decoding operation in the search space by using the probability as an input to obtain a word sequence corresponding to the characteristic vector sequence.

Abstract: A minimally invasive screw with double threaded plugs is provided, for connecting to a connecting rod. The screw includes an inner threaded plug, an outer threaded plug, a lengthened arm connector, a press block and a pin with a hollow ball head. The connecting rod can be fixed to the lengthened arm connector via the press block, the inner and outer threaded plugs, to prevent the vertebral body from rotating and loss of intervertebral height when the vertebral body is distracted and pressurized.

Abstract: A container-type biogas purification film method purification system comprises: a desulfurization and dehydration unit, a compressor, a purification unit, a heat exchanger, and a film-group purification and gas preparation unit that are disposed inside a movable container and are sequentially connected, the desulfurization and dehydration unit is connected to a biogas source generated by an anaerobic fermentation.

Abstract: The present disclosure relates to a pharmaceutical composition comprising: (a) ?-lactam antibiotics and (b) a metallo-?-lactamases (MBLs) inhibitor. The inhibitor relates to Bi(III) compounds or the pharmaceutically acceptable salts thereof. The present patent also provides methods of making Bi(III) compounds or the pharmaceutically acceptable salts thereof. Also provided is a method for treating MBLs-producing bacterial infection using a metal replacement mechanism.

Abstract: A minimally invasive screw with double threaded plugs is provided, for connecting to a connecting rod. The screw includes an inner threaded plug, an outer threaded plug, a lengthened arm connector, a press block and a pin with a hollow ball head. The connecting rod can be fixed to the lengthened arm connector via the press block, the inner and outer threaded plugs, to prevent the vertebral body from rotating and loss of intervertebral height when the vertebral body is distracted and pressurized.

Abstract: A curable resin including 1 part by weight of dianhydride, 0.8 to 1.5 parts by weight of diamine, and 1.5 to 5 parts by weight of vinyl monomer is disclosed. A blue photoresist, a color filter, and methods of preparing the same, and a color display device are also disclosed.

Abstract: A curable resin including 1 part by weight of dianhydride, 0.8 to 1.5 parts by weight of diamine, and 1.5 to 5 parts by weight of vinyl monomer is disclosed.

Abstract: Disclosed are a curable resin, a spacer composition, a filter, methods of preparing the same, a filter and a method of preparing the same, and a display device. The curable resin includes 1 part by weight of dianhydride, 0.6 to 2 parts by weight of diamine, and 0.8 to 3 parts by weight of vinyl monomer.

Abstract: Compounds which are glycosylates of an A-ring of a cardiotonic steroid, wherein the steroid is attached to the anomeric position of (a) a monosaccharide comprising a C-4 amino group, or (b) an oligosaccharide are provided.

Abstract: A container-type biogas purification film method purification system comprises: a desulfurization and dehydration unit, a compressor, a purification unit, a heat exchanger, and a film-group purification and gas preparation unit that are disposed inside a movable container and are sequentially connected, the desulfurization and dehydration unit is connected to a biogas source generated by an anaerobic fermentation.

Abstract: Phenyl propanoic acid compounds having activating effect on peroxisome proliferator-activated receptors (PPAR?,?,?) and a preparation method and uses thereof are provided in the present invention. The compounds can be used for treating or preventing diseases associated with peroxisome proliferator-activated receptors (PPAR?,?,?).

Abstract: A touch panel, a LCD device including the touch panel, a surface modification method for an IR material, and a touch panel provided with a component including an IR material obtained via the surface modification method are disclosed. A component including the IR material is disposed in the touch panel.

Abstract: Magnetic cores are described that include a first magnetic material with a first magnetic permeability, forming at least part of a body of the magnetic core, and a second magnetic material that has a second magnetic permeability positioned in a corner region of the body of the magnetic core. The second magnetic material is disposed within the body such that a plurality of magnetic flux paths of different overall lengths traverses the corner region. The plurality of potential magnetic flux paths have a corresponding plurality of effective magnetic reluctances, with different paths of the plurality of magnetic flux paths having different associated first lengths of a first plurality of lengths and different associated second lengths of a second plurality of lengths such that the corresponding plurality of magnetic reluctances of the plurality of magnetic flux paths are substantially equivalent through the different overall lengths.

Abstract: Phenyl propanoic acid compounds having activating effect on peroxisome proliferator-activated receptors (PPAR?,?,?) and a preparation method and uses thereof are provided in the present invention. The compounds can be used for treating or preventing diseases associated with peroxisome proliferator-activated receptors (PPAR?,?,?).

Abstract: The present invention relates to novel coumarin derivatives, their carboxamides, pharmaceutical compositions containing them and their uses as drugs for kidney protection, treating drugs of hypertension, cardio-cerebrovascular diseases, non-insulin dependent diabetes, tumor, pre-cancerous lesion, and edemas.